These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 26730050)

  • 1. Regression of Fibroadenomas with Centchroman: a Randomized Controlled Trial.
    Tejwani PL; Nerkar H; Dhar A; Kataria K; Hari S; Thulkar S; Chumber S; Kumar S; Srivastava A
    Indian J Surg; 2015 Dec; 77(Suppl 2):484-9. PubMed ID: 26730050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of centchroman in regression of mastalgia and fibroadenoma.
    Dhar A; Srivastava A
    World J Surg; 2007 Jun; 31(6):1178-84. PubMed ID: 17431715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluating the Effect of Ormeloxifene on Multiple Fibroadenomas and Mastalgia.
    Brahmachari S; Bhagat V; Patil P; Vasuniya V
    J Pharm Bioallied Sci; 2021 Nov; 13(Suppl 2):S1386-S1389. PubMed ID: 35017994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Double blind randomized controlled trial of efficacy of ormeloxifene for the treatment of fibroadenoma (The FIBROCENT study).
    Agrawal K; Silodia A; Yadav SK; Sharma DB; Sharma D
    World J Surg; 2024 May; 48(5):1177-1182. PubMed ID: 38498009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Centchroman as First-line Treatment for Mastalgia: Results of an Open-label, Single-arm Trial.
    Rathi J; Chawla I; Singh K; Chawla A
    Breast J; 2016 Jul; 22(4):407-12. PubMed ID: 27059808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Study Comparing Centchroman and Evening Primrose Oil in the Treatment of Benign Breast Disease.
    Sinha N; Tajdar Y; Pankaj D; Kumar N; Muni S; Bhushan V
    J Pharm Bioallied Sci; 2024 Apr; 16(Suppl 2):S1544-S1548. PubMed ID: 38882830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Centchroman regresses mastalgia: a randomized comparison with danazol.
    Tejwani PL; Srivastava A; Nerkar H; Dhar A; Hari S; Thulkar S; Chumber S; Kumar S
    Indian J Surg; 2011 Jun; 73(3):199-205. PubMed ID: 22654331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Centchroman vs tamoxifen for regression of mastalgia: a randomized controlled trial.
    Jain BK; Bansal A; Choudhary D; Garg PK; Mohanty D
    Int J Surg; 2015 Mar; 15():11-6. PubMed ID: 25619124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of Centchroman on Regression of Fibroadenosis and Mastalgia.
    Rajswaroob U; Kannan R; Kannan NS; Tirouaroul T
    J Clin Diagn Res; 2016 Oct; 10(10):PC10-PC14. PubMed ID: 27891390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosis and treatment of breast fibroadenomas by ultrasound-guided vacuum-assisted biopsy.
    Sperber F; Blank A; Metser U; Flusser G; Klausner JM; Lev-Chelouche D
    Arch Surg; 2003 Jul; 138(7):796-800. PubMed ID: 12860764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of fibroadenoma of the breast.
    Carty NJ; Carter C; Rubin C; Ravichandran D; Royle GT; Taylor I
    Ann R Coll Surg Engl; 1995 Mar; 77(2):127-30. PubMed ID: 7793802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized trial of Boswellia in association with betaine and myo-inositol in the management of breast fibroadenomas.
    Pasta V; Dinicola S; Giuliani A; Harrath AH; Alwasel SH; Tartaglia F; Cucina A; Bizzarri M
    Eur Rev Med Pharmacol Sci; 2016 May; 20(9):1860-5. PubMed ID: 27212181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phyllodes tumors and fibroadenoma common beginning and different ending.
    Oprić S; Oprić D; Gugić D; Granić M
    Coll Antropol; 2012 Mar; 36(1):235-41. PubMed ID: 22816226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estrogen receptor-alpha, bcl-2 and c-myc gene expression in fibroadenomas and adjacent normal breast: association with nodule size, hormonal and reproductive features.
    Cericatto R; Pozzobon A; Morsch DM; Menke CH; Brum IS; Spritzer PM
    Steroids; 2005 Mar; 70(3):153-60. PubMed ID: 15763593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Centchroman: is unsupervised long-term use warranted? Case report.
    Malhotra KP; Sherpa M; Bhatia A
    Eur J Contracept Reprod Health Care; 2011 Oct; 16(5):403-6. PubMed ID: 21777048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Percutaneous radiofrequency-assisted excision of fibroadenomas.
    Fine RE; Staren ED
    Am J Surg; 2006 Oct; 192(4):545-7. PubMed ID: 16978972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Office-based cryoablation of breast fibroadenomas: 12-month followup.
    Kaufman CS; Littrup PJ; Freman-Gibb LA; Francescatti D; Stocks LH; Smith JS; Henry CA; Bailey L; Harness JK; Simmons R
    J Am Coll Surg; 2004 Jun; 198(6):914-23. PubMed ID: 15194073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interim results from the FibroAdenoma Cryoablation Treatment Registry.
    Nurko J; Mabry CD; Whitworth P; Jarowenko D; Oetting L; Potruch T; Han L; Edwards MJ
    Am J Surg; 2005 Oct; 190(4):647-51; discussion 651-2. PubMed ID: 16164941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of growth hormone and growth hormone receptor in fibroadenomas of the breast.
    Lenicek T; Kasumović D; Stajduhar E; Dzombeta T; Jukić Z; Kruslin B
    Acta Clin Croat; 2013 Jun; 52(2):235-9. PubMed ID: 24053085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Indications for diagnostic open biopsy of mammographic screen-detected lesions preoperatively diagnosed as fibroadenomas by needle biopsy and their outcomes.
    Sala MA; Dhillon R; Brookes D; Lagrange C; Metcalf C; Wylie E
    Clin Radiol; 2015 May; 70(5):507-14. PubMed ID: 25656661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.